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Abstract 
Background: Persistent wound leakage after joint arthroplasty is a scantily investigated topic, despite 
the claimed relation with a higher risk of periprosthetic joint infection. This results in a lack of 
evidence-based clinical guidelines for the diagnosis and treatment of persistent wound leakage after joint 
arthroplasty. Without such guideline, clinical practice in orthopaedic hospitals varies widely. In 
preparation of a nationwide multicenter randomized controlled trial on the optimal treatment of 
persistent wound leakage, we evaluated current Dutch orthopaedic care for persistent wound leakage 
after joint arthroplasty.  
Methods: We conducted a questionnaire-based online survey among all 700 members of the 
Netherlands Orthopaedic Association, consisting of 23 questions on the definition, classification, 
diagnosis and treatment of persistent wound leakage after joint arthroplasty.  
Results: The questionnaire was completed by 127 respondents, representing 68% of the Dutch hospitals 
that perform orthopaedic surgery. The results showed wide variation in the classification, definition, 
diagnosis and treatment of persistent wound leakage among Dutch orthopaedic surgeons. 56.7% of the 
respondents used a protocol for diagnosis and treatment of persistent wound leakage, but only 26.8% 
utilized the protocol in every patient. Most respondents (59.1%) reported a maximum period of 
persistent wound leakage before starting non-surgical treatment of 3 to 7 days after index surgery and 
44.1% of respondents reported a maximum period of wound leakage of 10 days before converting to 
surgical treatment. 
Conclusions: The wide variety in clinical practice underscores the importance of developing an 
evidence-based clinical guideline for the diagnosis and treatment of persistent wound leakage after joint 
arthroplasty. To this end, a nationwide multicenter randomized controlled trial will be conducted in the 
Netherlands, which may provide evidence on this important and poorly understood topic. 










The diagnosis and treatment of persistent wound 
leakage is an important and poorly understood topic 
in the field of joint arthroplasty. Persistent wound 
leakage after total knee and hip arthroplasty is 
associated with a higher risk of developing 
periprosthetic joint infection (PJI).1–5 PJI is a serious 
complication with great impact on a patient’s physical 
functioning and quality of life. Moreover, PJI is a high 
financial burden for society. Additional medical costs 
of PJI are approximately €30,000 per patient,6,7 with 
even higher societal costs because of productivity loss, 
home care and informal care provided by relatives. 
Unfortunately, there are no evidence-based guidelines 
for the diagnosis and treatment of persistent wound 
leakage after joint arthroplasty.  
Numerous issues hamper the development of 
sound guidelines. First of all, research on wound 
leakage is hard, as PJI is the major endpoint of wound 
leakage treatment, which has a low incidence.8 
Secondly, there is no uniformly accepted definition of 
wound leakage or when to call it persistent. This lack 
of clear definitions hampers comparison of clinical 
reports to such an extent that there is no clear 
evidence for any treatment modality for persistent 
wound leakage. Finally, in clinical practice the 
amount of drainage may also play a role in the 
decision-making process, e.g. agreement on the 
optimal treatment of severe persistent wound leakage 
is usually easier than agreement on the treatment of 
less severe wound leakage.  
As a result of this lack of clarity, there is still 
insufficient evidence for the development of a clinical 
guideline. In 2013 consensus statements on current 
practices for prevention, diagnosis and management 
of PJI were developed during the first International 
Consensus Meeting (ICM) on PJI.9 One of these 
statements suggested that wound leakage is 
considered to be persistent when it continues for more 
than three days after index surgery. Moreover, they 
stated that surgical management of persistent wound 
leakage should be performed without delay if wound 
leakage persists for five to seven days after index 
surgery.10 However, there is no definitive evidence for 
these statements, as there have been no randomized 
controlled trials on persistent wound leakage.  
Without a guideline, clinical practice in 
orthopaedic hospitals varies widely. Moreover, there 
is no insight into the modalities used for diagnosis 
and treatment of persistent wound leakage after joint 
arthroplasty. This paper reports the results of a 
questionnaire-based online survey among Dutch 
orthopaedic surgeons on current care for persistent 
wound leakage after joint arthroplasty. The survey is 
part of the preparation for a nationwide multicenter 
randomized controlled trial in the Netherlands on the 
optimal treatment of persistent wound leakage after 
total knee and hip arthroplasty.  
Methods 
Procedure 
To evaluate current clinical practice of Dutch 
orthopaedic surgeons on persistent wound leakage 
after knee and hip arthroplasty, a questionnaire-based 
online survey was sent to all 700 members of the 
Netherlands Orthopaedic Association (NOV), 
working as orthopaedic surgeons in Dutch hospitals. 
Surveys completed by residents and members 
working outside the Netherlands were excluded. The 
web-based survey tool used for this questionnaire 
was google.forms. In January 2016 the questionnaire 
was disseminated by the NOV via e-mail invitation 
with a link to the survey. Reminder e-mails were sent 
after two and four weeks to increase the response rate. 
Data collection was closed six weeks after sending the 
first e-mail.  
Questionnaire 
The questionnaire consisted of 23 questions 
regarding the definition, classification, diagnosis and 
treatment of persistent wound leakage after 
arthroplasty (Supplementary Material). The 
questionnaire was developed by the LEAK-study 
group (LEakage After Knee and hip arthroplasty). 
This group was appointed by the Netherlands 
Orthopaedic Association (NOV) and its Consortium 
Orthopaedic Research (CORE), as part of the 
preparation for a nationwide multicenter randomized 
controlled trial on the treatment of persistent wound 
leakage after total knee and hip arthroplasty. The 
LEAK-study group involved 25 members who are 
experts in the field of prosthetic joint infections 
(orthopaedic surgeons, epidemiologists, researchers 
and an infectious disease specialist). Three consensus 
rounds were used to form the final questionnaire 
(Supplementary Material). 
Statistical analyses 
Statistical analyses were performed using IBM 
SPSS Statistics (version 23.0, Chicago, USA). Results 
were analyzed using descriptive statistics.  
Results 
Respondents 
A total of 127 respondents filled in the 
questionnaire (18.1% of NOV members), representing 
70 of all 103 institutions where knee and hip 
arthroplasty surgeries are performed (68.0%). Most 
respondents work in general non-training hospitals 




(61.4%) and 48.8% of the respondents had more than 
ten years of working experience (Table 1).    
Table 1. Descriptives of respondents (n=127) 
Variable Value Respondents (%) 
Clinic type General hospital 78 (61.4%) 
 Orthopaedic training hospital 39 (30.7%) 
 University hospital 10 (7.9%) 
Experience in years 0-10 65 (51.2%) 
 10-20 38 (29.9%) 
 >20 24 (18.9%) 
 
 
Classification and definition of wound leakage 
Most respondents did not use a classification 
system for wound leakage (81.2%) (Table 2). Of the 24 
respondents who reported using a classification 
system, 12 referred to their definition of wound 
leakage in days (9.4%) and the other 12 all used 
different classification systems (9.4%).  
Just over half of the respondents (51.2%) used a 
definition of persistent wound leakage, based on 
duration of wound leakage after index surgery (Table 
2). The used cut-off points showed a large range of 1 
to 14 days. Of the 65 respondents who used a 
definition of persistent wound leakage, 24 defined 
wound leakage as persistent when present for more 
than five days (36.9%), 11 as present for more than 
seven days (16.9%) and 19 for more than ten days 
(29.2%) (Figure 1a).  
Protocol for persistent wound leakage 
More than half of the respondents used a 
protocol for diagnosis and treatment of persistent 
wound leakage (56.7%), but only 26.8% utilized the 
protocol in every patient. Patients were regularly 
discharged by 48.8% of the respondents regardless of 
wound leakage. A similar percentage of respondents 
almost never discharged patients with wound leakage 
(43.3%). The majority of respondents reported 
monitoring patients after discharge (90.2%), e.g. via 
telephone consultation (Table 2).  
Diagnostic modalities 
Most clinical parameters used to evaluate 
persistent wound leakage were redness (92.9%), fever 
(92.9%), pain (69.3%), course of recovery (67.7%) 
and/or swelling (52.7%). Warmth was evaluated by 
fewer respondents (38.6%). Nearly all respondents 
used a combination of at least three clinical 
parameters (86.6%) (Figure 2a). The most popular 
combination was redness, fever, course of recovery 
and pain (used by 42.5% of the respondents), with 
another 27.5% of the respondents evaluating these 
parameters in combination with warmth and 
swelling.  
 For inflammatory parameters, plasma C-reactive 
protein (CRP) was used as a diagnostic modality by 
92.1% of respondents. Similarly, most (82.7%) 
perceived CRP as the most important inflammatory 
parameter in persistent wound leakage. Moreover, 
70.9% of the respondents felt that the trend or 
dynamics of CRP are important.   
 
Table 2. Definition, classification and protocol for wound leakage 
(n=127) 
Variable Value Respondents (%) 
Classification for wound leakage Yes 24 (18.8%) 
 No 103 (81.2%) 
Uniform definition of wound leakage Yes 65 (51.2%) 
 No 62 (48.8%) 
Uniform protocol in case of wound 
leakage 
Yes, used in all cases 34 (26.8%) 
 Yes, not always 
used 
38 (29.9%) 
 No 55 (43.3%) 
Discharge patients with wound 
leakage 
Yes, always 4 (3.2%) 
 Yes, regularly 62 (48.8%) 
 No, almost never 55 (43.3%) 
 No, never 6 (4.7%) 
Monitoring wound leakage after 
discharge* 
Yes 111 (90.2%) 
 No 12 (9.8%) 
* 4 missing values  
 
Non-surgical treatment modalities 
The maximum period of persistent wound 
leakage before starting non-surgical treatment was 3 
to 7 days according to most respondents (59.1%) 
(Figure 1b). 20.5% of respondents stated no maximum 
period before starting non-surgical treatment, as they 
only use surgical treatment modalities. The 
miscellaneous group used clinical presentation 
instead of the above-mentioned time-based parameter 
(10.2%).  
 Regarding non-surgical treatment modalities for 
persistent wound leakage most respondents used 
wound care (60.6%), bed rest (49.6%), pressure 
bandages (36.2%), admittance (23.6%) and antibiotics 
(23.6%). A wide variety of combinations was reported 
(in total 36), all comprising small groups (ranging 
from 1 to 8 respondents): 54.4% of the respondents 
used 1-2 non-surgical treatment modalities, 40.9% 
used 3-4 modalities and 4.7% reported using 5-7 
modalities (Figure 2b). The most popular combination 
was admittance and wound care (5.5%).  
Surgical treatment modalities 
Most respondents reported a maximum period 
of wound leakage before converting to surgical 
treatment of 10 days after index surgery (44.1%) 
(Figure 1c), yet with a wide range from 5 to 21 days. 
From the miscellaneous group (31.5%), 14 




respondents favored a 14-day cut-off, while another 
14 respondents stated basing their decision on aspects 
other than duration of wound leakage (e.g. type 
and/or amount of wound leakage, clinical parameters 
and/or inflammatory parameters).  
 The most-used surgical treatment modalities 
were lavage (96.1%), obtaining cultures (94.4%), 
surgical debridement (79.5%), antibiotics (77.2%) and 
exchange of mobile components (67.7%). The majority 
of the respondents (52.0%) favored a combined use of 
all these five treatment modalities as a surgical 
treatment regime; 34.6% of respondents used 3-4 
surgical treatment modalities and 13.4% used 1-2 
modalities (Figure 2c). The miscellaneous group 
(3.1%) comprised of two respondents using local 
gentamicin carriers, one removing the prosthesis and 
one other respondent performing only superficial 
debridement in case of an intact joint capsule and 
iliotibial tract.  
Discussion 
In this online survey we evaluated current Dutch 
orthopaedic care for persistent wound leakage after 
joint arthroplasty. This survey revealed considerable 
variation in clinical practice among Dutch 
orthopaedic surgeons in terms of classification, 
definition, diagnosis and treatment of persistent 
wound leakage after joint arthroplasty. This variety in 
clinical practice is likely the result of a lack of 
evidence-based guidelines, caused by the scarce 
evidence on this topic.1–5,10–12 
Regarding the definition of persistent wound 
leakage after joint arthroplasty most respondents 
based the definition on the duration of wound leakage 
after index surgery. Preferred cut-off points were 
more than five days and more than ten days, yet with 
a large range (1 to 14 days). This lack of agreement is 
in accordance with reports in the literature, reporting 
using time (with a range of 2 to 7 days), presence of 
microbial content or type of secretion (purulent, 
hematogenous or clear) as definition.1–5,11–16 The ICM 
statements define persistent wound leakage as a 
wound leaking >2 x 2cm for more than three days, 
arguing that this time frame would allow for earlier 
intervention and may limit the claimed adverse 
consequences (e.g. PJI). 10 Still, there is no scientific 





Figure 1. Definition of persistent wound leakage and maximum period of wound leakage before start of (non-)surgical treatment (n=127)             




Figure 2. Clinical parameters, non-surgical treatment modalities and surgical treatment (n=127) 2a. Clinical parameters 2b. Non-surgicaltreatment 
modalities 2c. Surgical treatment modalities. 




In the Netherlands there is dearth of a uniform 
approach to the classification, definition, diagnosis 
and treatment of persistent wound leakage. Only 
18.7% of respondents used a classification and all 
used a different classification. In the literature there is 
a complete lack of data regarding amount of wound 
leakage, while this amount and its dynamics play a 
large role in the decision-making process. This 
missing classification of type and amount of wound 
leakage impairs comparison and interpretation of the 
scarce literature on the topic.  
This survey showed that there is no consensus 
on a protocol. Only 26.5% used a protocol 
consistently, and 30.5% did not use the protocol in all 
cases. In the literature only Maathuis et al. have 
described a standardized method to approach 
persistent wound leakage after arthroplasty.1 
Compared to an ad hoc approach, their algorithm 
resulted in fewer open debridements (17% versus 
30%) and a higher salvage percentage (95% versus 
85%).  
 The clinical parameters most respondents used 
when evaluating persistent wound leakage were 
redness, fever, pain, swelling and a course of 
recovery. A combination of at least two clinical 
parameters was used by nearly all respondents 
(96.9%). However, 24 different combinations were 
reported, underscoring an apparent lack of evidence 
and consensus for an optimal combination of clinical 
parameters.  
 Our results showed that orthopaedic surgeons 
used several clinical and inflammatory parameters to 
provide the necessary information to guide clinical 
decision-making. For inflammatory parameters, 
92.1% of respondents used CRP at some point in their 
decision-making process. Moreover, most 
respondents reported CRP to be the primary 
parameter and 70.9% reported that the trend or 
dynamics of CRP are important - e.g. a rise in CRP is 
considered a worrisome sign, whereas a decrease is 
generally interpreted as a sign of absence of infection. 
Nevertheless, responses to the exact use of CRP were 
wide and diverse, probably in relation to the fact that 
an elevated CRP, as well as some other clinical 
infectious symptoms (such as fever and tachycardia), 
may be a physiological response in the early 
postoperative period.17–23 
In this survey the maximum period of wound 
leakage before starting non-surgical treatment was 
three to seven days after index surgery. The most 
popular treatment modalities included wound care, 
bed rest, pressure bandages and/or antibiotics. Still, 
more than 30 combinations of treatment modalities 
were used, stressing the lack of consensus on optimal 
non-surgical treatment. Literature on this topic is 
limited, suggesting several days of 
immobilization,15,16 sterile dressings,3 and/or 
antibiotics.3 The use of antibiotics among 23.4% of 
respondents was a surprising and disturbing finding, 
as the efficacy of antibiotic treatment in persistent 
wound leakage after arthroplasty has not been 
studied. Antibiotics can also have substantial negative 
effects, such as increased risk of resistance, poor 
penetration into the biofilm, and complicated early 
diagnosis and treatment of infection, given that they 
can mask infection and confound culture findings.10,15 
For these reasons, the ICM advises against the use of 
antibiotics in persistent wound leakage after joint 
arthroplasty.9,10 
 Most respondents (43.8%) convert to surgical 
treatment if wound leakage is present for ten days 
after index surgery, implying a non-surgical 
treatment period of three to seven days. The literature 
offers little guidance on this topic, but suggests that 
wound leakage more than five to nine days after 
arthroplasty should be managed by surgical 
treatment to give a higher chance of preventing 
PJI.2–4,14,16 Based on these findings, the ICM states that 
surgical treatment should be performed if wound 
leakage persists for more than five to seven days.10 
However, it seems reasonable to use parameters other 
than merely duration of wound leakage in the clinical 
decision-making process. In this survey a minority of 
respondents used other aspects, such as type or 
amount of wound leakage, clinical parameters and/or 
infectious parameters. 
 A total of 16 combinations were reported as 
surgical treatment protocol. The majority (52.3%) 
favored a combined protocol consisting of five 
modalities (surgical debridement, lavage, cultures, 
exchange of mobile components, and start of 
antibiotic treatment). These modalities are 
comparable to the ICM’s, stating a moderate 
agreement on deep open debridement, cultures (>3) 
and modular component exchange.10,24 
This survey can be viewed as a fair 
representation of the practices of the Dutch 
orthopaedic community. The main weakness of this 
study is that it is by design a questionnaire-based 
survey. Although this study design led to a relatively 
low response rate of 18.1% among all NOV members, 
the respondents represented the majority (68.0%) of 
orthopaedic clinics, which leads to a reasonable 
assumption that respondents provided a correct 
representation of clinical practice in the Netherlands. 
Respondents were not obliged to fill in the name of 
the hospital they worked in, since it was anticipated 
that orthopaedic surgeons could consider this a 
barrier for filling in the survey. Because of this, 15 
respondents did not provide data on the hospital they 




worked in. Taking this into account, the actual 
representation of orthopaedic clinics may be even 
higher than 68.0%.  
In conclusion, the data from this nationwide 
survey among Dutch orthopaedic surgeons on 
persistent wound leakage after joint arthroplasty 
demonstrated a wide variation in clinical practice of 
classification, definition, diagnosis and treatment of 
persistent wound leakage. This underscores the lack 
of consensus, which is mainly due to a dearth of clear 
evidence on the correct diagnosis and treatment of 
wound leakage. This survey may be representative for 
current daily clinical practice of the global 
orthopaedic community and stresses the need for 
further research on this important topic.  
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